VX-702

VX-702
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-V9202.5 5 mg -

3 - 8 business days*

90.00€
LKT-V9202.25 25 mg -

3 - 8 business days*

173.00€
LKT-V9202.100 100 mg -

3 - 8 business days*

416.00€
 
VX-702 inhibits p38 MAPK, preventing p38 MAPK-dependent inflammatory cytokine release. VX-702 is... more
Product information "VX-702"
VX-702 inhibits p38 MAPK, preventing p38 MAPK-dependent inflammatory cytokine release. VX-702 is in development to treat inflammation and cardiovascular diseases and currently shows mixed results in clinical trials as a potential treatment for rheumatoid arthritis. In vitro, VX-702 decreases platelet lesioning in storage without affecting platelet function.
Keywords: VX702
Supplier: LKT Laboratories
Supplier-Nr: V9202

Properties

Application: p38 MAPK inhibitor
MW: 404.32 D
Purity: >98%
Format: Solid

Database Information

CAS : 479543-46-9| Matching products
KEGG ID : K04441 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "VX-702"
Write a review
or to review a product.
Viewed